Actively Recruiting

Age: 6Years +
All Genders
NCT06891898

The iLet Experience Study

Led by Beta Bionics, Inc. · Updated on 2025-03-24

1875

Participants Needed

1

Research Sites

160 weeks

Total Duration

On this page

Sponsors

B

Beta Bionics, Inc.

Lead Sponsor

T

The Scripps Research Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

A one-year, prospective single-arm cohort study to collect safety and effectiveness data on the iLet Dosing Decision Software during real-world use in people 6 years of age or older with type 1 diabetes (T1D) with 12 months follow-up.

CONDITIONS

Official Title

The iLet Experience Study

Who Can Participate

Age: 6Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with type 1 diabetes and prescribed the iLet Bionic Pancreas System
  • At least 6 years of age
  • Using or planning to use U100 Novolog (insulin aspart), U100 Humalog (insulin lispro) in ready-to-fill cartridges, or U100 Fiasp PumpCart (insulin aspart) in pre-filled 1.6mL cartridges
  • Willing to provide HbA1c results from within 6 months before starting the iLet and during the last 6 months of study participation
  • Willing to provide CGM data if available from the 1 month before starting the iLet
  • For females, not pregnant or planning pregnancy in the next 12 months
  • Able to respond to alerts and alarms and perform basic diabetes self-management
  • Reside full-time in the US
  • Able to speak and read English
  • Willing and able to download the iLet Mobile App, keep it active throughout the study, and upload device data regularly
  • Willing to answer baseline and monthly surveys and share CGM and follow-up data as needed
Not Eligible

You will not qualify if you...

  • Diagnosis of type 2 diabetes, cystic fibrosis-related diabetes, congenital hyperinsulinism, pancreatogenic diabetes, or any diabetes other than type 1
  • Use or planned use of any insulin with the iLet other than U100 Novolog, U100 Humalog, or U100 Fiasp PumpCart cartridges
  • End-stage renal disease requiring peritoneal dialysis or hemodialysis
  • Use or planned use of hydroxyurea

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Beta Bionics

Irvine, California, United States, 92618

Actively Recruiting

Loading map...

Research Team

C

Courtney Balliro, BS RN

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The iLet Experience Study | DecenTrialz